Skip to contentBAKER BROS. ADVISORS LP — GENOMIC HEALTH INC insider: 556 transactions · InsiderLensBAKER BROS. ADVISORS LP
- Director at SYNTA PHARMACEUTICALS CORP · on record since Jun 20, 2023
- Former 10% Owner at Atreca, Inc. · on record since Oct 23, 2023
- Former 10% Owner at Neurogene Inc. · on record since Dec 20, 2023
- Former 10% Owner at SEATTLE GENETICS INC /WA · on record since Dec 18, 2023
- 10% owner at Mirati Therapeutics, Inc. · on record since Oct 28, 2013
- Director at vTv Therapeutics Inc. · on record since Mar 7, 2024
- Director at Immunocore Holdings plc · on record since May 29, 2024
- Director at BICYCLE THERAPEUTICS PLC · on record since May 29, 2024
- 10% owner at BICYCLE THERAPEUTICS PLC · on record since May 29, 2024
- 10% owner at Kala Pharmaceuticals, Inc. · on record since Jun 28, 2024
- Director at Kymera Therapeutics, Inc. · on record since Apr 1, 2024
- Director at TScan Therapeutics, Inc. · on record since May 22, 2026
- 10% owner at SERA PROGNOSTICS, INC. · on record since Feb 14, 2025
- Former 10% owner and director at IGM Biosciences, Inc. · on record since Aug 18, 2025
- 10% owner at Celcuity Inc. · on record since Sep 10, 2025
- 10% owner at Kymera Therapeutics, Inc. · on record since Dec 11, 2025
- Former 10% owner at Kala Pharmaceuticals, Inc. · on record since Oct 2, 2025
- Director at INCYTE CORP · on record since Apr 2, 2026
- 10% owner at INCYTE CORP · on record since Apr 2, 2026
- Director at Replimune Group, Inc. · on record since Apr 7, 2026
- 10% owner at Replimune Group, Inc. · on record since Apr 7, 2026
- Director at BeOne Medicines Ltd. · on record since May 27, 2026
- Director at Prelude Therapeutics Inc · on record since Apr 22, 2026
- 10% owner at Prelude Therapeutics Inc · on record since Apr 22, 2026
- Director at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Apr 24, 2012
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Apr 24, 2012
- Director at GENOMIC HEALTH INC · on record since May 23, 2012
- 10% owner at GENOMIC HEALTH INC · on record since May 23, 2012
- 10% owner at XOMA LTD /DE/ · on record since Apr 23, 2012
- 10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Apr 23, 2012
- Director at SEATTLE GENETICS INC /WA · on record since Apr 23, 2012
- 10% owner at SEATTLE GENETICS INC /WA · on record since Apr 23, 2012
- Director at TRIMERIS INC · on record since Apr 23, 2012
- 10% owner at TRIMERIS INC · on record since Apr 23, 2012
- Director at XOMA LTD /DE/ · on record since Oct 31, 2012
- 10% owner at ACADIA PHARMACEUTICALS INC · on record since Dec 21, 2012
- Director at ACADIA PHARMACEUTICALS INC · on record since Jan 23, 2013
- 10% owner at MAYTAG CORP · on record since Jul 11, 2013
- Director at IDERA PHARMACEUTICALS, INC. · on record since Mar 19, 2014
- Director at Kiniksa Pharmaceuticals International, plc · on record since Jun 2, 2026
- Director at Denali Therapeutics Inc. · on record since Jun 5, 2026
- Director at ALEXION PHARMACEUTICALS INC · on record since Jun 30, 2015
- Former 10% owner and Director at TRIMERIS INC · on record since Jun 23, 2015
- 10% owner at Invitae Corp · on record since Aug 27, 2015
- Former 10% owner at XOMA LTD /DE/ · on record since Jul 23, 2015
- 10% owner at Neurogene Inc. · on record since Sep 11, 2015
- 10% owner at BELLICUM PHARMACEUTICALS, INC · on record since Dec 24, 2015
- 10% owner at BeOne Medicines Ltd. · on record since Feb 9, 2016
- Former 10% owner at Intellia Therapeutics, Inc. · on record since May 11, 2016
- 10% owner at Intellia Therapeutics, Inc. · on record since May 5, 2016
- Director at Neurogene Inc. · on record since May 9, 2017
- Former 10% Owner at Mirati Therapeutics, Inc. · on record since Nov 20, 2017
- Former 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 6, 2017
- 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 4, 2017
- 10% owner at IDERA PHARMACEUTICALS, INC. · on record since Mar 15, 2018
- 10% owner at Kiniksa Pharmaceuticals International, plc · on record since May 31, 2018
- 10% owner at Principia Biopharma Inc. · on record since Sep 13, 2018
- Director at Kodiak Sciences Inc. · on record since Oct 11, 2018
- 10% owner at Kodiak Sciences Inc. · on record since Oct 11, 2018
- 10% owner at Atreca, Inc. · on record since Jun 26, 2019
- Former 10% owner at REDHOOK ALE BREWERY INC · on record since Apr 23, 2019
- 10% owner at REDHOOK ALE BREWERY INC · on record since Apr 18, 2019
- Director at IGM Biosciences, Inc. · on record since Sep 20, 2019
- 10% owner at IGM Biosciences, Inc. · on record since Sep 20, 2019
- Director at SMI PRODUCTS INC · on record since Dec 20, 2019
- 10% owner at SMI PRODUCTS INC · on record since Oct 15, 2019
- Director at Zymeworks Inc. · on record since Mar 16, 2020
- Director at Spyre Therapeutics, Inc. · on record since Feb 25, 2021
- Director at Talis Biomedical Corp · on record since Feb 19, 2021
- 10% owner at Talis Biomedical Corp · on record since Feb 19, 2021
- Director at DBV Technologies S.A. · on record since Jan 11, 2021
- 10% owner at DBV Technologies S.A. · on record since Jan 11, 2021
- 10% owner at TScan Therapeutics, Inc. · on record since Jul 15, 2021
- 10% owner at Entrada Therapeutics, Inc. · on record since Dec 16, 2021
Insider trading activity of BAKER BROS. ADVISORS LP
- Transactions on record
- 556
- since May 8, 2012
- Open-market buys
- 282
- $1.1B
- Open-market sells
- 79
- $41.1M
- Companies traded
- 28
- last filing Jul 2, 2026
Figures computed from official regulatory filings — methodology.
Companies where BAKER BROS. ADVISORS LP has traded
- Kodiak Sciences Inc.37 tx · $36.2M · Jul 2, 2026
- INCYTE CORP30 tx · $16M · Jul 2, 2026
- vTv Therapeutics Inc.2 tx · Jun 29, 2026
- Kymera Therapeutics, Inc.6 tx · Jun 25, 2026
- SYNTA PHARMACEUTICALS CORP30 tx · $297.5M · Jun 18, 2026
- BeOne Medicines Ltd.21 tx · $640.7M · Jun 15, 2026
- Prelude Therapeutics Inc8 tx · $10.1M · Jun 10, 2026
- Denali Therapeutics Inc.8 tx · Jun 5, 2026
- ACADIA PHARMACEUTICALS INC42 tx · $33.6M · Jun 2, 2026
Track record of BAKER BROS. ADVISORS LP
Statistical track record
Free- Open-market buys
- 294
- Last buy
- Apr 21, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of BAKER BROS. ADVISORS LP
Co-insiders of BAKER BROS. ADVISORS LP
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
6 tx · $29.2M · Jun 2, 2026
LEVY RICHARD SINCYTE CORP +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 2, 2026 | Award | 400 | 0.00 USD | — | SEC |
| Jul 2, 2026 | AwardD | 17,731 | 0.00 USD | — | SEC |
| Jul 2, 2026 | Award | 400 | 0.00 USD | — | SEC |
| Jul 2, 2026 | AwardD | 17,731 | 0.00 USD | — | SEC |
| Jun 29, 2026 | AwardD | 6,000 | 0.00 USD | — | SEC |
| Jun 29, 2026 | AwardD | 6,000 | 0.00 USD | — | SEC |
| Jun 25, 2026 | AwardD | 6,068 | 0.00 USD | — | SEC |
| Jun 25, 2026 | AwardD | 6,068 | 0.00 USD | — | SEC |
| Jun 18, 2026 | Award | 908 | 0.00 USD | — | SEC |
| Jun 18, 2026 | AwardD | 1,532 | 0.00 USD | — | SEC |
| Jun 18, 2026 | Award | 908 | 0.00 USD | — | SEC |
| Jun 18, 2026 | AwardD | 1,532 | 0.00 USD | — | SEC |
| Jun 15, 2026 | Award | 18,980 | 0.00 USD | $0 | SEC |
| Jun 15, 2026 | Award | 18,980 | 0.00 USD | $0 | SEC |
| Jun 10, 2026 | AwardD | 38,000 | 0.00 USD | $0 | SEC |
| Jun 10, 2026 | Award | 1,642 | 0.00 USD | $0 | SEC |
| Jun 10, 2026 | AwardD | 6,111 | 0.00 USD | $0 | SEC |
| Jun 10, 2026 | AwardD | 38,000 | 0.00 USD | $0 | SEC |
| Jun 10, 2026 | AwardD | 6,111 | 0.00 USD | $0 | SEC |
| Jun 10, 2026 | Award | 1,642 | 0.00 USD | $0 | SEC |
| Jun 5, 2026 | AwardD | 19,226 | 0.00 USD | $0 | SEC |
| Jun 5, 2026 | AwardD | 19,226 | 0.00 USD | $0 | SEC |
| Jun 5, 2026 | Award | 6,408 | 0.00 USD | $0 | SEC |
| Jun 5, 2026 | Award | 6,408 | 0.00 USD | $0 | SEC |
| Jun 2, 2026 | AwardD | 32,008 | 0.00 USD | $0 | SEC |